[BRIEFING.COM] - Nordic American Tankers (NAT) is a new member of our GROWX rankings. NAT is a crude oil tanker operator whose earnings are highly leveraged to changes in global tanker rates and utilization. The company is benefiting from a much stronger tanker market as geopolitical disruptions and longer shipping routes have tightened vessel availability and pushed freight rates higher, creating a favorable environment for NAT's fleet of Suezmax tankers. 
There are several new additions to the Top 25 this week. SBC Medical Group (SBC #9) is a medical services
organization providing management support to medical institutions in Japan and
abroad across a wide range of healthcare fields, including aesthetic
healthcare, dermatology, orthopedics, fertility treatment, gynecology,
dentistry, hair-loss treatment, and ophthalmology. Its services include
advertising and marketing, staffing and recruitment, booking and reservations,
clinic development, procurement, IT solutions, and the licensing of medical
technologies and trademarks. SBC also operates clinics in Singapore and Vietnam
while expanding through strategic investments and alliances in the U.S. A key
catalyst was its Q2 report on August 13, and shares have continued their
momentum since then. Revenue growth reaccelerated, increasing 13% yr/yr to $49
mln, with CEO Yoshiyuki Aikawa saying the results marked a new phase of growth
as SBC increasingly leverages the convergence of healthcare and AI. The company
is using more than 26 years of accumulated data across AI-powered call centers,
marketing, and site selection to improve clinic operations and support growth
in locations, fees per clinic, and service offerings. As patient visits and
treatment volumes increase, clinics can grow and generate higher service fees
for SBC, creating a virtuous growth cycle. That reaccelerating growth is also
translating into significant operating leverage, with adjusted EBITDA rising
32% yr/yr to $20 mln and margin expanding 600 bps to 41%. Looking ahead, SBC
plans to deepen its multi-brand aesthetic dermatology strategy, expand its
non-aesthetic business, and accelerate international growth through OrangeTwist
in the U.S. and ASEAN. Nordic American Tankers (NAT #20) is a crude oil tanker operator
whose earnings are highly leveraged to changes in global tanker rates and
utilization. The company is benefiting from a much stronger tanker market as
geopolitical disruptions and longer shipping routes have tightened vessel
availability and pushed freight rates higher, creating a favorable environment
for NAT's fleet of Suezmax tankers. Management's latest commentary has pointed
to exceptionally strong conditions for its vessels, while its Q2 report
highlighted improving rates and vessel values, reinforcing the earnings and
asset-value leverage to a stronger tanker cycle. The stock has responded
sharply, climbing from roughly $3.50 in early January to above $8 now. We think
the key attraction is NAT's relatively straightforward exposure to tanker
rates: when rates rise, cash generation can increase rapidly, while higher
vessel values can provide another source of shareholder value. NAT also has a
long history of returning cash to shareholders through dividends, although the
payout can fluctuate meaningfully with tanker-market conditions. The biggest
risk is that the stock has already moved substantially higher and therefore has
greater exposure to a reversal in freight rates; a normalization in
geopolitical conditions, shorter trade routes or an increase in tanker supply
could quickly pressure day rates and earnings. With NAT shares now trading near
their recent highs, the stock appears increasingly tied to whether the current
strength in the tanker market can persist rather than simply whether the
underlying shipping industry remains healthy. On a final note, NAT is paying a
hefty 9.9% dividend yield, but again if rates decline, that could be at risk. Dorian LPG (LPG #22) is an owner and operator of very large gas carriers (VLGCs) that transport liquefied petroleum gas, primarily propane and butane, around the world. The company is benefiting from a powerful combination of strong US LPG exports, long-distance trade flows and tight VLGC availability, which has pushed shipping rates sharply higher and translated into outsized earnings growth. Dorian's Q1 (Jun) earnings report showed the leverage to this environment, with revenue more than doubling yr/yr to $187.9 mln. More recently, the outlook has strengthened further: Dorian estimated that 99% of its calendar days for Q2 (Sep) were fixed at rates above $88,000/day, providing unusually strong near-term earnings visibility. The stock has reflected that improvement, climbing more than 60% since late June, making LPG one of the more significant beneficiaries of the stronger VLGC market. Dorian recently ordered three dual-fuel Panamax VLGCs for $345 mln, with deliveries scheduled for 2030. The key risk is that LPG shipping remains a highly cyclical business: today's exceptional rates are supported by strong export demand and favorable trade economics, but a weaker US-to-Asia arbitrage, normalization of geopolitical disruptions or an expanding vessel orderbook could eventually pressure freight rates. With shares having already rallied substantially, the stock's future performance will increasingly depend on whether elevated VLGC rates can remain high. SentinelOne (S #25) is a cybersecurity software company whose Singularity platform protects enterprise endpoints, cloud workloads, security data, identities, and AI applications through products including Singularity Endpoint, Cloud Security, AI SIEM, Purple AI, Prompt Security, and Wayfinder, serving large enterprises, governments, telecom operators, managed-security providers, and regulated organizations globally. Its growth strategy centers on displacing legacy endpoint vendors, consolidating multiple security tools onto one autonomous platform, moving upmarket through larger enterprise contracts, cross-selling faster-growing data, cloud, and AI-security products, and using SentinelOne Flex to simplify multiproduct adoption. In Q2, reported August 27, revenue increased 21% yr/yr to $292 mln, while ARR rose 22% to $1.218 bln and record second-quarter net new ARR of $56 mln grew 4%, extending net-new-ARR growth to five consecutive quarters. Customers generating at least $100,000 of ARR increased 13% yr/yr, slower than the prior quarter's 17% growth, but ARR per customer reached a record and dollar-based net retention among these large accounts improved yr/yr and sequentially for a third straight quarter, indicating that larger initial contracts and cross-selling are outweighing slower customer-count expansion. Non-GAAP operating margin reached a record 10%, expanding 820 bps yr/yr, while sales and marketing expense declined by more than 900 bps to 34% of revenue, demonstrating meaningful operating leverage as sales productivity, deal sizes, and renewal automation improve. Forward visibility also strengthened as RPO climbed 45% to $1.7 bln, supported by larger and longer-duration commitments, prompting SentinelOne to raise FY27 revenue guidance to $1.202-$1.207 bln and non-GAAP operating-income guidance to $124-$128 mln, although Q3 revenue guidance near consensus explains some investor caution after the stock's strong pre-report advance. The strongest growth catalysts are AI-security ARR from Prompt Security and Purple AI tripling yr/yr, SentinelOne Flex surpassing 10% of total ARR within one year, accelerating data and cloud-security adoption, sovereign and air-gapped deployment capabilities, and a large legacy-antivirus replacement opportunity, giving the company credible prospects for sustained growth and margin expansion if it continues converting its pipeline amid intense cybersecurity competition. 
There is one deletion this week: EVER (weakening relative strength).
Emerging Growth Stocks is Briefing.com's proprietary quantitative system designed to uncover small, fast-growing companies that have the potential to become market leaders.
If you're new to this page, each Monday we publish an updated list of the top 25 small- and mid-cap growth stocks in the market. These companies are discovered and ranked using a quantitative screen that removes emotion and bias from the process, and which places a heavy emphasis on current and forward-looking indicators such as strong 6-month Relative Strength, fast-growing quarterly sales and EPS, expanding margins, etc. In addition, on the Live In Play page our analysts periodically publish fundamental and technical commentary under the "GROWX" ticker on EG components that have significant news, notable technical characteristics, or are just names that we find interesting.
We'd like to emphasize that the EG system was created in order to generate new growth stock ideas every week, regardless of market conditions. As such, readers should understand that Emerging Growth was specifically designed to be an idea generation system, and not a portfolio timing system.
| Emerging Growth: September 21, 2026 |
| Ranks #1-25: We begin tracking performance of new additions to the Top 25 |
| 1 |
CareDx |
CDNA |
|
$54.08 |
|
Industry: |
Medical Specialties |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $2,785 |
1,168 |
47 |
12% |
98% |
100 |
331% |
59% |
52% |
16% |
| Date Added & Original Profile: |
20-Jul-26 |
Price Added: |
$38.38 |
% Gain/Loss |
+41% |
Most Recent Analysis: |
-- |
| CDNA is a precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Its core portfolio includes AlloSure blood tests for kidney, heart, and lung transplant recipients and AlloMap gene-expression testing for heart recipients, alongside digital tools, pharmacy services, and patient-support solutions. A key recent catalyst was the final Medicare Local Coverage Determination, which affirmed surveillance-testing coverage across CDNA's kidney, heart, and lung offerings. Essentially, the policy confirmed continued Medicare coverage for routine noninvasive surveillance testing, easing concerns about tighter restrictions and providing greater visibility into CDNA's recurring testing business. The reimbursement update followed a strong Q1 report that comfortably exceeded expectations. Growth reflected higher average revenue per test, a favorable surveillance-testing mix, and stronger for-cause testing. Patient and Digital Solutions revenue rose 33% to $16 mln, while Lab Products revenue declined 4% to $10 mln. Non-GAAP gross margin expanded 500 bps to 73%, while adjusted EBITDA increased to $19 mln from $5 mln, driven by revenue growth, improved operating leverage, operational efficiency, and cost discipline. On a final note, CDNA will report Q2 results on July 30 after the close. [7/20/26] |
| 2 |
Eurodry Ltd. |
EDRY |
|
$70.16 |
|
Industry: |
Marine Shipping |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $197 |
139 |
2 |
9% |
96% |
100 |
322% |
99% |
57% |
-1% |
| Date Added & Original Profile: |
10-Aug-26 |
Price Added: |
$36.75 |
% Gain/Loss |
+91% |
Most Recent Analysis: |
-- |
| EDRY is a small-cap drybulk shipping company operating Panamax, Kamsarmax, Ultramax and Supramax vessels that transport commodities including iron ore, coal and grains. While drybulk shipping is highly cyclical, EuroDry has exposure to improving freight rates, high fleet utilization and significant operating leverage. The company maintained 99% fleet utilization in 2025, while two Ultramax newbuilds scheduled for delivery in 2027 will expand its fleet and earning capacity. Recent results also show improving momentum. The stock has been moving sharply since its Q2 report last week when revenue jumped 57% yr/yr to $17.7 mln. It was also a highly profitable quarter, EDRY's strongest in four years. During Q2, the drybulk market strengthened significantly, with time charter rates reaching levels last seen in 2022. This positive momentum continued into July and is also reflected in FFA rates for the remainder of 2026 and throughout 2027. The strength of the market primarily reflects increased demand for drybulk vessels, driven by higher overall drybulk trade, including stronger volumes of iron ore and bauxite, an even short term recovery in coal trade, longer average voyage distances, and transportation inefficiencies and trade dislocations stemming from ongoing geopolitical developments and uncertainty. EDRY remains an attractive higher-risk way to play a potential continuation of the drybulk upcycle. However, we would use caution as the company is very small. [8/10/26] |
| 3 |
Orion Energy Systems |
OESX |
|
$27.34 |
|
Industry: |
Semiconductors |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $112 |
89 |
3 |
3% |
88% |
100 |
218% |
605% |
32% |
9% |
| Date Added & Original Profile: |
31-Aug-26 |
Price Added: |
$22.56 |
% Gain/Loss |
+21% |
Most Recent Analysis: |
-- |
| OESX is a provider of energy-efficient LED lighting (Orion Lighting), electric vehicle charging stations and maintenance services serving enterprise, industrial and commercial customers. While the company has faced several difficult years of declining revenue and losses, its turnaround is starting to gain meaningful traction. Orion is beginning to benefit from multiple secular growth opportunities, including LED lighting upgrades, EV charging infrastructure and the emerging demand for lighting and electrical solutions within data centers. In Q1 (Jun), reported a 32% yr/yr jump in revenue to $25.7 mln. Orion believes it's on a path of increasing profitability and continued market expansion in FY27. Growth drivers range from Orion's expanding business within large customers to a multimillion-dollar entry into the burgeoning hyper-scale data center market to an array of new Orion offerings. Orion entered the hyper-scale data center market with an LED lighting offering specifically designed for this massive market in Q1. Quickly following the product announcement, Orion was awarded a multimillion-dollar customer engagement with one of the world's largest hyper-scale data centers. OESX has similarly high aspirations for its newly introduced LED Roadway product designed for public roads. There are positives, but we would use caution as the company is small and we view it as still somewhat speculative. [8/31/26] |
| 4 |
AtriCure |
ATRC |
|
$58.04 |
|
Industry: |
Medical Specialties |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $2,955 |
1,065 |
49 |
8% |
97% |
100 |
238% |
#N/A |
13% |
1% |
| Date Added & Original Profile: |
17-Aug-26 |
Price Added: |
$45.54 |
% Gain/Loss |
+27% |
Most Recent Analysis: |
-- |
| ATRC is a medical-device company focused on surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain. Its primary end markets are hospitals and cardiac and thoracic surgery programs, where surgeons use its technologies during open and minimally invasive procedures to treat Afib, reduce stroke-related risks, and manage post-operative pain. Q2 worldwide revenue increased 12.8% yr/yr to $153.6 mln. Key growth catalysts include accelerating adoption of cryoSPHERE MAX and cryoXT, continued penetration of the smaller AtriClip FLEX-Mini and PRO-Mini devices, broader use of the EnCompass clamp, and eventual clinical readouts from the BoxX-NoAF and LeAAPS trials that could expand treatment guidelines and AtriCure's addressable market. [8/17/26] |
| 5 |
Quantum Corp |
QMCO |
|
$26.08 |
|
Industry: |
Computer Peripherals |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $989 |
1,541 |
25 |
7% |
94% |
100 |
111% |
#N/A |
26% |
8% |
| Date Added & Original Profile: |
17-Aug-26 |
Price Added: |
$24.92 |
% Gain/Loss |
+5% |
Most Recent Analysis: |
-- |
| QMCO delivers end-to-end data management solutions designed for unstructured data in the AI era. In simple terms, QMCO helps customers store, manage and protect massive amounts of data across its lifecycle. It specializes in video, images, audio and other large files, with unstructured data representing more than 80% of data being created.QMCO shares surged last week following its strong 1Q27 report on Aug. 10. Revenue increased 26% yr/yr to $80.8 mln, exceeding guidance, supported by strong enterprise demand for ActiveScale and tape storage solutions, better pricing, fixed-cost leverage and restructuring-driven expense reductions. Demand indicators were also encouraging, with backlog increasing significantly, its tape opportunity funnel reaching its highest level in years and a sharp increase in $1+ mln deals, including an eight-figure hyperscaler deployment. QMCO also exited the quarter debt-free and generated positive operating cash flow, with adjusted net income turning positive for the first time since 2023. Notably, management said near-term revenue upside is being constrained more by its ability to secure and ship tape and disk drives than by customer demand, with backlog and bookings remaining strong, making its ability to work through supply constraints a key focus going forward. [8/17/26] |
| 6 |
Ethos Technologies |
LIFE |
|
$36.17 |
|
Industry: |
Packaged Software |
| Market Cap (mln) |
B |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $1,136 |
1,344 |
13 |
10% |
85% |
99 |
999% |
494% |
113% |
62% |
| Date Added & Original Profile: |
10-Aug-26 |
Price Added: |
$32.12 |
% Gain/Loss |
+13% |
Most Recent Analysis: |
-- |
| LIFE went public earlier this year and is a technology-driven life insurance platform focused on making coverage easier to access and purchase through its direct-to-consumer and third-party agent channels. LIFE provides a streamlined process that allows consumers to explore, compare and purchase life insurance policies entirely online. LIFE is licensed in 49 states and partners with top-rated insurance carriers. LIFE delivered another strong report as a public company in Q2, comfortably exceeding expectations on the top and bottom line. Revenue surged 113.5% yr/yr to $189.6 mln, marking its second consecutive quarter of triple-digit growth. The company is on pace for a fourth consecutive year of more than 50% revenue growth, while its raised FY26 outlook implies further acceleration from 2025. Growth has been fueled by expanding consumer adoption, improving marketing efficiency and rapid growth across its third-party agent network. Reflecting its strong first-half performance and continued momentum, LIFE raised FY26 revenue guidance to $727-$731 mln from $561-$565 mln and adjusted EBITDA guidance to $119-$123 mln from $103-$107 mln. [8/10/26] |
| 7 |
Okeanis Eco Tankers | ECO |
|
$85.16 |
|
Industry: |
Marine Shipping |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $3,317 |
572 |
20 |
4% |
98% |
99 |
612% |
28% |
239% |
22% |
| Date Added & Original Profile: |
14-Sep-26 |
Price Added: |
$75.91 |
% Gain/Loss |
+12% |
Most Recent Analysis: |
-- |
| ECO is a crude-oil tanker company operating a modern fleet of Suezmax and VLCC vessels. ECO combines strong near-term tanker-market earnings with a young fleet, significant operating leverage and an unusually shareholder-friendly capital-return profile. The company operates 16 modern vessels, including eight Suezmax and eight VLCC tankers, positioning it well to benefit from strong crude transportation demand and elevated tanker rates. ECO has continued to benefit from strong tanker-market conditions. The company also maintains a strong liquidity position, giving it flexibility to navigate the cyclical tanker market while continuing to return substantial cash to shareholders. The stock has already had an exceptional run, up more than 60% since late May, meaning the market has clearly recognized the improvement in tanker earnings. We caution that tanker rates are cyclical and ECO could see a pullback if rates decline. However, the combination of a modern fleet, strong spot-market exposure, high current earnings and significant dividend capacity provides an attractive setup if tanker fundamentals remain supportive. ECO recently increased its quarterly dividend substantially to $5.25/sh from $2.00/sh, and now boasts a 12.1% annual yield. But that could be at risk if tanker rates decline. [9/14/26] |
| 8 |
Eton Pharma |
ETON |
|
$56.72 |
|
Industry: |
Pharmaceuticals: Major |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $1,586 |
581 |
27 |
5% |
85% |
99 |
450% |
84% |
99% |
39% |
| Date Added & Original Profile: |
20-Jul-26 |
Price Added: |
$41.21 |
% Gain/Loss |
+38% |
Most Recent Analysis: |
-- |
| ETON is a specialty pharma co focused on rare diseases. ETON delivered strong Q1 results on May 14, with total net revenue rising 40% yr/yr to $24.3 mln and product sales and royalty revenue increasing 73%, driven by broad-based growth from INCRELEX, ALKINDI SPRINKLE, GALZIN, Carglumic Acid, and the addition of KHINDIVI. ETON raised its 2026 revenue outlook from $110 mln to more than $120 mln and continues to expect an adjusted EBITDA margin of at least 30%, reflecting confidence in continued growth from the existing portfolio and meaningful contributions from the recently launched DESMODA and relaunched HEMANGEOL. ETON's growth strategy centers on acquiring or developing differentiated rare-disease products that can be commercialized through its existing specialist sales infrastructure and supported by its Eton Cares patient-access platform, allowing new assets to be added with attractive operating leverage. Major longer-term catalysts include DESMODA's estimated $30-$50 mln peak-sales opportunity, broader adoption of HEMANGEOL and KHINDIVI, a potential INCRELEX label expansion that could increase the addressable U.S. population from roughly 200 to 1,000 patients, a KHINDIVI pediatric label expansion, and the advancement of ET-700 as a potentially improved extended-release treatment for Wilson disease. [7/20/26] |
| 9 |
SBC Medical |
SBC |
|
$5.21 |
|
Industry: |
Miscellaneous Commercial Services |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $489 |
149 |
19 |
4% |
105% |
99 |
400% |
-14% |
13% |
8% |
| Date Added & Original Profile: |
21-Sep-26 |
Price Added: |
$5.21 |
% Gain/Loss |
+0% |
Most Recent Analysis: |
-- |
| SBC is a medical services organization providing management support to medical institutions in Japan and abroad across a wide range of healthcare fields, including aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair-loss treatment, and ophthalmology. Its services include advertising and marketing, staffing and recruitment, booking and reservations, clinic development, procurement, IT solutions, and the licensing of medical technologies and trademarks. SBC also operates clinics in Singapore and Vietnam while expanding through strategic investments and alliances in the US. A key catalyst was its Q2 report on August 13, and shares have continued their momentum since then. Revenue growth reaccelerated, increasing 13% yr/yr to $49 mln, with CEO Yoshiyuki Aikawa saying the results marked a new phase of growth as SBC increasingly leverages the convergence of healthcare and AI. Looking ahead, SBC plans to deepen its multi-brand aesthetic dermatology strategy, expand its non-aesthetic business, and accelerate international growth through OrangeTwist in the U.S. and ASEAN. [9/21/26] |
| 10 |
American Outdoor |
AOUT |
|
$16.57 |
|
Industry: |
Recreational Products |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $207 |
176 |
11 |
2% |
99% |
99 |
112% |
#N/A |
25% |
5% |
| Date Added & Original Profile: |
8-Sep-26 |
Price Added: |
$15.07 |
% Gain/Loss |
+10% |
Most Recent Analysis: |
-- |
| AOUT supplies outdoor lifestyle and shooting-sports products across hunting, fishing, outdoor cooking etc. Key growth catalysts include new products, which generated an unusually high 36% of quarterly sales, continued positive point-of-sale trends, expansion of Caldwell's ClayCopter platform, growth in BUBBA's connected fishing ecosystem and paid subscriptions, normalized channel inventories, and further gains across e-commerce and international markets. [9/8/26] |
| 11 |
PBF Energy |
PBF |
|
$75.89 |
|
Industry: |
Oil Refining/Marketing |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $9,150 |
3,333 |
102 |
11% |
92% |
98 |
704% |
50% |
56% |
22% |
| Date Added & Original Profile: |
3-Aug-26 |
Price Added: |
$72.22 |
% Gain/Loss |
+5% |
Most Recent Analysis: |
-- |
| PBF is one of the largest independent petroleum refiners in North America, producing gasoline, diesel, jet fuel and other refined products. While the refining industry has experienced a volatile earnings environment as crack spreads (margin between crude oil and refined gasoline) normalized from the record highs seen in recent years, we believe PBF is well positioned to benefit from improving supply-demand fundamentals and a more disciplined refining landscape. One of the biggest reasons we like the story is the limited addition of new refining capacity in North America, which should support healthy margins over the long term even as demand growth moderates. At the same time, management has been focused on improving operational reliability, optimizing refinery utilization, reducing debt and enhancing its product mix while investing in renewable fuels and other lower-carbon opportunities through its ownership interest in the St. Bernard Renewables joint venture. Those efforts should help generate stronger cash flow across commodity cycles while positioning the company for evolving energy markets. The stock has really come on strong since mid-June as crack spreads have risen sharply in recent weeks due to strong summer fuel demand, constrained refining capacity, and geopolitical disruptions. Recent Middle East tensions and concerns about fuel exports have increased the risk of supply disruptions for refined products, pushing gasoline and diesel prices up faster than crude oil prices. [8/3/26] |
| 12 |
Magnite |
MGNI |
|
$25.25 |
|
Industry: |
Packaged Software |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $3,607 |
2,531 |
140 |
8% |
94% |
98 |
30% |
7% |
11% |
6% |
| Date Added & Original Profile: |
10-Aug-26 |
Price Added: |
$24.53 |
% Gain/Loss |
+3% |
Most Recent Analysis: |
-- |
| MGNI provides technology solutions that automate the purchase and sale of digital advertising inventory. It operates one of the largest independent sell-side advertising platforms across CTV, mobile, desktop and other digital formats, helping publishers and media owners monetize their advertising inventory. Unlike The Trade Desk (TTD), which operates primarily on the demand side and helps advertisers purchase media, MGNI sits primarily on the supply side, connecting publisher inventory with advertisers and DSPs. MGNI has become particularly well positioned in connected TV through its SpringServe platform, which helps streaming publishers manage ad serving, programmatic monetization and demand across premium inventory. The company is benefiting from the continued shift of advertising dollars toward streaming, increasing programmatic adoption within CTV and market-share gains among major media owners. MGNI reported its Q2 results on August 5, sending shares sharply higher. Adjusted EPS modestly exceeded expectations, while revenue jumped 11.3% yr/yr to $192.8 mln, nicely above estimates. MGNI also raised its FY26 outlook, now expecting contribution ex-TAC growth of 13-14%, adjusted EBITDA growth above 20%, and adjusted EBITDA margin of at least 37%. [8/10/26] |
| 13 |
Elastic NV |
ESTC |
|
$89.05 |
|
Industry: |
Packaged Software |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $9,130 |
2,416 |
91 |
4% |
82% |
98 |
17% |
20% |
15% |
2% |
| Date Added & Original Profile: |
8-Sep-26 |
Price Added: |
$88.84 |
% Gain/Loss |
+0% |
Most Recent Analysis: |
-- |
| ESTC is a search and data analytics software company that helps businesses search, monitor and secure massive amounts of data through its Elasticsearch platform. While the company has faced concerns around slowing growth and the potential impact of AI on traditional software spending, Elastic is increasingly well positioned to benefit from the AI-driven expansion of enterprise data. A positive to the story is the company's exposure to Search AI, where customers are using Elastic's technology to power AI applications. In late August, ESTC reported strong Q1 (Jul) results beating prior guidance across all key metrics, which caused a gap higher in the shares. Customer demand was strong across all areas, especially in Search & AI and Security. ESTC ended Q1 with more than 1,800 customers spending $100,000 or more in ACV. This is the highest sequential net additions to this $100,000 metric that ESTC has ever seen. Its 21% cRPO growth and 27% RPO growth signal that customers are continuing to make multi-year commitments to its platform as long-term AI transformations are taking hold. ESTC explained that AI is reshaping the stack that developers build upon. The focus is no longer on tokenmaxxing. It is on building agentic applications that leverage the reasoning and inferencing power of LLMs on a business's proprietary data. This requires the highest possible retrieval accuracy at the lowest possible cost. That shift plays directly to Elastic strengths. [9/8/26] |
| 14 |
Aya Gold & Silver |
AYA |
|
$28.39 |
|
Industry: |
Precious Metals |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $4,099 |
1,025 |
140 |
#N/A |
93% |
97 |
999% |
#N/A |
151% |
#N/A |
| Date Added & Original Profile: |
10-Aug-26 |
Price Added: |
$27.54 |
% Gain/Loss |
+3% |
Most Recent Analysis: |
-- |
| AYA is a Morocco-focused precious metals producer and explorer anchored by the producing Zgounder Silver Mine and the exploration-stage Boumadine polymetallic project, with a growing portfolio targeting silver, gold, copper, lead, zinc, cobalt and other metals across the country. The stock is trading at record highs, buoyed by rising precious-metals prices and improving operating performance at Zgounder. AYA recently expanded its exploration pipeline by acquiring three mining licenses and 18 exploration permits. Operationally, Q2 marked another significant step forward as consolidated production surged 61% yr/yr and 12% sequentially to a record 1.68 Moz silver equivalent, including record Zgounder production of 1.49 Moz silver, while processing reached a record 3,889 tpd and the combined open-pit and underground mining rate hit a record 4,880 tpd with silver recovery of 91.2%. Zgounder's continued ramp-up, the planned crusher expansion, a growing ore stockpile, increased H2 shipping capacity from Boumadine's temporary pyrite-reclamation operation, an expanding Moroccan exploration footprint, and potential discoveries at Boumadine and the newly acquired properties provide multiple avenues for growth, while elevated silver and gold prices could amplify the financial benefits of higher production and future resource development. [8/10/26] |
| 15 |
Frequency Electronics |
FEIM |
|
$87.22 |
|
Industry: |
Telecommunications Equipment |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $964 |
366 |
10 |
10% |
97% |
97 |
486% |
173% |
70% |
31% |
| Date Added & Original Profile: |
14-Sep-26 |
Price Added: |
$85.43 |
% Gain/Loss |
+2% |
Most Recent Analysis: |
-- |
| FEIM is a niche defense and space electronics company that designs high-precision timing, frequency-control and synchronization products used in satellites, GPS systems, missiles etc. FEIM is benefiting from several long-term secular tailwinds, including increased defense spending, the growing number of satellites and the need for assured positioning, navigation and timing in GPS-denied environments. The stock surged following its impressive Q1 (Jul) earnings report last week. Revenue jumped 70% yr/yr and 52% sequentially to a record $23.5 mln. On its Q4 call, FEIM said it expected to return to growth starting in FY27 and this first quarter was a strong proof point of that. Further, the Q1 results gives FEIM increasing confidence it will meet or exceed its long-term FY29 annual revenue outlook of $150+ mln. Its funded backlog reached a record $129 mln at the end of Q1, up 82% yr/yr and 16% sequentially, as well as by its growing order book and the significantly larger end-markets that FEIM is now selling into. Also, FEIM remains debt-free and its balance sheet was significantly enhanced by a secondary offering during the quarter, which added $73 mln in cash. In short, FEIM says business is booming and it sees many attractive organic growth opportunities. [9/14/26] |
| 16 |
Hinge Health |
HNGE |
|
$94.57 |
|
Industry: |
Packaged Software |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $5,928 |
1,834 |
53 |
10% |
98% |
97 |
69% |
-4% |
53% |
6% |
| Date Added & Original Profile: |
29-Jun-26 |
Price Added: |
$83.37 |
% Gain/Loss |
+13% |
Most Recent Analysis: |
-- |
| HNGE is a leading technology platform for treating and preventing joint and muscle pain. The company uses software and AI to deliver personalized care across acute injuries, chronic pain, and pre- and post-surgical rehabilitation. Its platform combines AI-powered motion tracking, exercise therapy, the Enso pain-relief device, and support from physical therapists, physicians, and health coaches. HNGE primarily serves self-insured employers, with health plans, PBMs, and other partners helping distribute the platform. Growth is being driven by client expansion, greater member adoption within existing clients, entry into new markets, and the launch of additional programs and capabilities. HNGE reported Q1 results on May 5, beating expectations on the top and bottom lines. Revenue increased 47.2% yr/yr to $182.3 mln, while LTM calculated billings climbed 52% to $769.9 mln. The upside reflected stronger-than-expected enrollment and engagement, with new clients converting members faster, existing clients seeing greater participation, and both new and established accounts covering more employees than anticipated. Longer term, HNGE sees substantial runway in the underpenetrated MSK market, while strong initial demand for Migraine Care supports expansion into additional conditions. [6/29/26] |
| 17 |
Zeta Global |
ZETA |
|
$30.26 |
|
Industry: |
Packaged Software |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $6,874 |
7,996 |
223 |
11% |
92% |
97 |
58% |
11% |
44% |
5% |
| Date Added & Original Profile: |
10-Aug-26 |
Price Added: |
$27.26 |
% Gain/Loss |
+11% |
Most Recent Analysis: |
-- |
| ZETA provides an AI-powered marketing and customer intelligence platform that combines proprietary consumer data, identity resolution, analytics, workflow automation, and omnichannel activation. The stock has pushed to new 52-week highs following its August 4 Q2 report, when revenue surged 44% yr/yr to $443 mln, or 28% excluding M&A. ZETA raised its 2026 revenue guidance midpoint by $33 mln to $1.818 bln, implying 39% growth, while also lifting adjusted EBITDA guidance to $405 mln and free cash flow guidance by $20 mln to $255 mln, supported by a sales pipeline that grew more than 60% yr/yr and by management's view that core demand remains robust and durable. The most important long-term catalyst is accelerating AI adoption through Athena, where more than 40% of super-scaled customers are already monthly active users and comprehensive AI adopters show materially stronger growth, retention, and wallet expansion, giving ZETA a potentially powerful land-and-expand flywheel. Beyond Athena, partnerships with OpenAI, Snowflake, and Palantir, the rollout of Zeta Business Intelligence, a developing marketing-cloud replacement cycle, and continued gains in sales productivity should expand ZETA's addressable market. [8/10/26] |
| 18 |
Insight Enterprises |
NSIT |
|
$155.17 |
|
Industry: |
Information Technology Services |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $4,546 |
377 |
29 |
3% |
92% |
97 |
58% |
32% |
15% |
10% |
| Date Added & Original Profile: |
10-Aug-26 |
Price Added: |
$150.96 |
% Gain/Loss |
+3% |
Most Recent Analysis: |
-- |
| NSIT is an IT solutions provider helping businesses deploy hardware, software, cloud and AI technologies. Basically, Insight is part IT consultant, part technology reseller and part implementation/service company. NSIT sits between technology vendors (Microsoft, Cisco, Dell, Google) and organizations that need technology, helping the organization choose, purchase, implement, and manage it. While softer hardware demand weighed on results in recent years, the story is improving as Insight shifts toward higher-margin services, cloud and AI solutions. The stock has risen nicely since its Q2 report in early August wherein sales rose 15% yr/yr to $2.40 bln. Infrastructure hardware revenue rose more than 20%, reflecting strong demand across servers, storage and networking as clients modernize their environment and invest in AI-ready infrastructure. For the year, NSIT expects corporate and large enterprise clients spending to improve from last year. NSIT expects core services gross profit will grow in the low double-digits with contribution from our recent acquisitions as well as improvement our organic business. NSIT should continue to benefit from enterprise AI adoption, where Insight's relationships with thousands of technology partners and large corporate customers position it to benefit as AI moves from experimentation toward broader deployment. [8/10/26] |
| 19 |
Andersen Group |
ANDG |
|
$54.26 |
|
Industry: |
Other Consumer Services |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $749 |
449 |
14 |
15% |
94% |
96 |
999% |
298% |
24% |
9% |
| Date Added & Original Profile: |
20-Jul-26 |
Price Added: |
$43.46 |
% Gain/Loss |
+25% |
Most Recent Analysis: |
-- |
| ANDG is a provider of tax, valuation and financial advisory services to businesses, investment firms, and high-net-worth individuals. The investment case centers on the growing demand for outsourced professional services as companies navigate increasingly complex tax regulations, transaction activity, and financial reporting requirements. Andersen has built its business by expanding its service offerings and geographic footprint, allowing it to cross-sell higher-value advisory work while benefiting from recurring client relationships. In December 2025, its IPO priced at $16 and opened at $21. Since then, investors have been rewarded handsomely as investors have grown more optimistic about the company's ability to generate consistent organic growth and margin expansion despite an uneven M&A and capital markets environment. Even after the stock's advance, the market may still be underappreciating Andersen's long runway for growth as businesses continue shifting more tax planning, valuation, and compliance work to specialized third-party advisors. Unlike traditional accounting firms that rely heavily on audit work, Andersen has meaningful exposure to higher-growth advisory and consulting services, which can provide stronger pricing power and profitability over time. [7/20/26] |
| 20 |
Nordic American Tankers |
NAT |
|
$8.19 |
|
Industry: |
Marine Shipping |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $1,747 |
3,676 |
200 |
8% |
98% |
96 |
999% |
#N/A |
57% |
#N/A |
| Date Added & Original Profile: |
21-Sep-26 |
Price Added: |
$8.19 |
% Gain/Loss |
+0% |
Most Recent Analysis: |
-- |
| NAT is a crude oil tanker operator whose earnings are highly leveraged to changes in global tanker rates and utilization. The company is benefiting from a much stronger tanker market as geopolitical disruptions and longer shipping routes have tightened vessel availability and pushed freight rates higher, creating a favorable environment for NAT's fleet of Suezmax tankers. The stock has responded sharply, climbing from roughly $3.50 in early January to above $8 now. We think the key attraction is NAT's relatively straightforward exposure to tanker rates: when rates rise, cash generation can increase rapidly, while higher vessel values can provide another source of shareholder value. NAT also has a long history of returning cash to shareholders through dividends, although the payout can fluctuate meaningfully with tanker-market conditions. The biggest risk is that the stock has already moved substantially higher and therefore has greater exposure to a reversal in freight rates; a normalization in geopolitical conditions, shorter trade routes or an increase in tanker supply could quickly pressure day rates and earnings. On a final note, NAT is paying a hefty 9.9% dividend yield, but again if rates decline, that could be at risk. [9/21/26] |
| 21 |
MiniMed |
MMED |
|
$21.63 |
|
Industry: |
Medical Specialties |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $6,131 |
1,659 |
27 |
30% |
89% |
96 |
999% |
#N/A |
17% |
2% |
| Date Added & Original Profile: |
14-Sep-26 |
Price Added: |
$21.80 |
% Gain/Loss |
-1% |
Most Recent Analysis: |
-- |
| MMED is a diabetes technology company focused on insulin pumps, continuous glucose monitoring and automated insulin delivery systems. MMED is being separated from Medtronic (MDT). MiniMed has several advantages, including more than 40 years of insulin-pump experience and a broad portfolio spanning pumps, sensors and automated insulin-delivery technology, allowing it to compete across more of the diabetes-management ecosystem than more narrowly focused rivals such as Dexcom (DXCM) and Insulet (PODD). The company is also advancing new products, including the MiniMed Flex and MiniMed Fit patch pump, while its Simplera and Instinct sensor offerings expand its CGM capabilities. MMED offers an interesting combination of a growing end market, an established product portfolio and a corporate-structure catalyst that could support further value creation over the next several years. [9/14/26] |
| 22 |
Dorian LPG |
LPG |
|
$57.95 |
|
Industry: |
Marine Shipping |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $2,488 |
594 |
37 |
5% |
97% |
96 |
833% |
19% |
123% |
17% |
| Date Added & Original Profile: |
21-Sep-26 |
Price Added: |
$57.95 |
% Gain/Loss |
+0% |
Most Recent Analysis: |
-- |
| LPG is an owner and operator of very large gas carriers (VLGCs) that transport liquefied petroleum gas, primarily propane and butane, around the world. The company is benefiting from a powerful combination of strong US LPG exports, long-distance trade flows and tight VLGC availability, which has pushed shipping rates sharply higher and translated into outsized earnings growth. Dorian's Q1 (Jun) earnings report showed the leverage to this environment, with revenue more than doubling yr/yr to $187.9 mln. More recently, the outlook has strengthened further: Dorian estimated that 99% of its calendar days for Q2 (Sep) were fixed at rates above $88,000/day, providing unusually strong near-term earnings visibility. The stock has reflected that improvement, climbing more than 60% since late June, making LPG one of the more significant beneficiaries of the stronger VLGC market. Dorian recently ordered three dual-fuel Panamax VLGCs for $345 mln, with deliveries scheduled for 2030. The key risk is that LPG shipping remains a highly cyclical business: today's exceptional rates are supported by strong export demand and favorable trade economics, but a weaker US-to-Asia arbitrage, normalization of geopolitical disruptions or an expanding vessel orderbook could eventually pressure freight rates. [9/21/26] |
| 23 |
Lifestance Health |
LFST |
|
$12.55 |
|
Industry: |
Medical/Nursing Services |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $4,804 |
4,416 |
261 |
5% |
#N/A |
96 |
700% |
83% |
26% |
5% |
| Date Added & Original Profile: |
6-Jul-26 |
Price Added: |
$11.42 |
% Gain/Loss |
+10% |
Most Recent Analysis: |
-- |
| LFST operates one of the nation's largest outpatient mental health platforms, providing virtual and in-person care to children, adolescents, and adults across a broad range of conditions. LFST also handles scheduling, billing, payor contracting, and other administrative functions, allowing clinicians to focus more directly on patient care. The company's growth strategy centers on expanding within existing markets, entering new ones, and leveraging its scalable platform to address a large, fragmented market constrained by limited access, affordability, provider capacity, and care coordination. LFST delivered a strong beat-and-raise Q1 on May 7. Revenue increased 21.2% yr/yr to $403.5 mln, driven by an 18% increase in visit volume to 2.5 mln and a 3% increase in revenue per visit. Visit growth reflected an 11% larger clinician base and a 7% improvement in visits per average clinician. Shares have continued to strengthen since the report, recently reaching new 52-week highs and rising roughly 60% YTD. The latest leg higher has coincided with recent strength across healthcare, although LFST's improving clinician productivity, strong operating leverage, positive free cash flow, and raised outlook provide company-specific support. [7/6/26] |
| 24 |
Forum Energy |
FET |
|
$82.34 |
|
Industry: |
Oilfield Services/Equipment |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $942 |
193 |
10 |
6% |
94% |
96 |
999% |
105% |
13% |
7% |
| Date Added & Original Profile: |
17-Aug-26 |
Price Added: |
$86.45 |
% Gain/Loss |
-5% |
Most Recent Analysis: |
-- |
| FET is an energy equipment manufacturer that supplies drilling, completion, production, subsea, and processing products - including coiled tubing, wireline cables, iron roughnecks, remotely operated vehicles, artificial-lift systems, sand-control equipment, and valves - to oil and natural gas, defense, and renewable-energy customers. Its principal end markets span onshore and offshore drilling, well construction and stimulation, subsea operations, hydrocarbon production and processing, and specialized marine and defense applications. In Q2, revenue increased 8% sequentially and 13% yr/yr to $226 mln, while orders of $236 mln produced a 104% book-to-bill ratio and reinforced backlog visibility. Growth should be supported by market-share gains, strong subsea and downhole orders, increased demand for coiled tubing, wireline cables, artificial-lift and flow-control products, and better plant utilization following facility consolidation. [8/17/26] |
| 25 |
SentinelOne |
S |
|
$23.48 |
|
Industry: |
Packaged Software |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $7,703 |
8,017 |
325 |
6% |
97% |
96 |
100% |
12% |
21% |
1% |
| Date Added & Original Profile: |
21-Sep-26 |
Price Added: |
$23.48 |
% Gain/Loss |
+0% |
Most Recent Analysis: |
-- |
| SentinelOne is a cybersecurity software company whose Singularity platform protects enterprise endpoints, cloud workloads, security data, identities, and AI applications through products including Singularity Endpoint, Cloud Security, AI SIEM, Purple AI, Prompt Security, and Wayfinder, serving large enterprises, governments, telecom operators, managed-security providers, and regulated organizations globally. Its growth strategy centers on displacing legacy endpoint vendors, consolidating multiple security tools onto one autonomous platform, moving upmarket through larger enterprise contracts, cross-selling faster-growing data, cloud, and AI-security products, and using SentinelOne Flex to simplify multiproduct adoption. In Q2, reported August 27, revenue increased 21% yr/yr to $292 mln, while ARR rose 22% to $1.218 bln and record second-quarter net new ARR of $56 mln grew 4%. The strongest growth catalysts are AI-security ARR from Prompt Security and Purple AI tripling yr/yr, SentinelOne Flex surpassing 10% of total ARR within one year, accelerating data and cloud-security adoption, sovereign and air-gapped deployment capabilities, and a large legacy-antivirus replacement opportunity, giving the company credible prospects for sustained growth and margin expansion if it continues converting its pipeline amid intense cybersecurity competition. [9/21/26] |
| Ranks #26-100: We continue to track performance until they drop below Rank #100 |
| Rank |
Name |
Ticker |
Industry |
Mkt Cap |
6-Mo RS |
Q EPS % |
Q Rev % |
Date Added |
% Gain/Loss |
| #26 |
Red Violet |
RDVT |
Packaged Software |
$1,219 |
96 |
79% |
23% |
8-Sep-26 |
+2% |
| #27 |
Flotek Industries |
FTK |
Oilfield Services/Equipment |
$1,137 |
96 |
63% |
70% |
-- |
-- |
| #28 |
Varonis Systems |
VRNS |
Packaged Software |
$5,463 | 96 |
33% | 19% |
6-Jul-26 |
+8% |
| #29 |
RCM Tech |
RCMT |
Personnel Services |
$280 |
96 |
19% |
20% |
17-Aug-26 |
+1% |
| #30 |
International Seaways |
INSW |
Marine Shipping |
$5,505 |
95 |
479% |
140% |
-- |
-- |
| #31 |
Tsakos Energy |
TEN |
Marine Shipping |
$1,534 |
95 |
368% |
54% |
-- |
-- |
| #32 |
Backblaze |
BLZE |
Computer Peripherals |
$815 | 95 |
700% | 18% |
11-May-26 |
+87% |
| #33 |
Teekay Tankers |
TNK |
Marine Shipping |
$3,033 |
95 |
294% |
63% |
-- |
-- |
| #34 |
e.l.f. Beauty |
ELF |
Household/Personal Care |
$5,691 | 95 |
97% | 36% |
24-Aug-26 |
-9% |
| #35 |
Newsmax |
NMAX |
Broadcasting |
$928 |
95 |
103% |
17% |
24-Aug-26 |
-1% |
| #36 |
Ultrapar Participacoes |
UGP |
Specialty Stores |
$8,458 |
95 |
45% |
37% |
-- |
-- |
| #37 |
Kiniksa Pharma |
KNSA |
Pharmaceuticals: Major |
$3,730 |
95 |
30% |
55% |
-- |
-- |
| #38 |
Bowman Consulting |
BWMN |
Engineering & Construction |
$736 | 95 |
13% | 20% |
-- | -- |
| #39 |
MaxLinear, Inc. |
MXL |
Semiconductors |
$7,357 |
94 |
999% |
55% |
-- |
-- |
| #40 |
Safe Bulkers |
SB |
Marine Shipping |
$935 |
94 |
999% |
33% |
-- |
-- |
| #41 |
Metalla Royalty |
MTA |
Financial Conglomerates |
$952 |
94 |
150% |
94% |
24-Aug-26 |
-10% |
| #42 |
Pagaya Technologies |
PGY |
Packaged Software |
$1,473 | 94 |
145% | 15% |
3-Aug-26 |
-3% |
| #43 |
Xometry |
XMTR |
IT Services |
$5,427 |
94 |
78% |
41% |
-- |
-- |
| #44 |
Intapp |
INTA |
Packaged Software |
$2,770 | 94 |
52% | 13% |
10-Aug-26 |
-6% |
| #45 |
GigaCloud |
GCT |
Wholesale Distributors |
$1,524 |
94 |
27% |
28% |
-- |
-- |
| #46 |
Mako Mining |
MAKO |
Precious Metals |
$923 |
93 |
999% |
62% |
-- |
-- |
| #47 |
Par Pacific |
PARR |
Oil Refining/Marketing |
$4,227 |
93 |
556% |
57% |
-- |
-- |
| #48 |
TORM PLC |
TRMD |
Marine Shipping |
$3,916 | 93 |
452% | 110% |
-- | -- |
| #49 |
Hafnia Limited |
HAFN |
Marine Shipping |
$5,058 |
93 |
227% |
47% |
-- |
-- |
| #50 |
Anika Therapeutics |
ANIK |
Medical Specialties |
$278 |
93 |
423% |
16% |
3-Aug-26 |
-0% |
| #51 |
Kolibri Global |
KGEI |
Oil & Gas Production |
$245 |
93 |
188% |
109% |
-- |
-- |
| #52 |
Seanergy Maritime |
SHIP |
Marine Shipping |
$403 | 92 |
633% | 49% |
-- | -- |
| #53 |
Bullish |
BLSH |
Packaged Software |
$5,763 |
92 |
283% |
66% |
-- |
-- |
| #54 |
Twin Disc |
TWIN |
Trucks/Construction |
$362 | 92 |
540% | 18% |
-- | -- |
| #55 |
Navios Maritime Partners LP |
NMM |
Marine Shipping |
$2,631 |
92 |
116% |
25% |
-- |
-- |
| #56 |
Pro-Dex |
PDEX |
Medical Specialties |
$232 |
92 |
142% |
17% |
-- |
-- |
| #57 |
Harmony Biosciences |
HRMY |
Pharmaceuticals: Major |
$2,447 |
92 |
88% |
30% |
-- |
-- |
| #58 |
Marcus Corp |
MCS |
Movies/Entertainment |
$660 | 92 |
122% | 12% |
3-Aug-26 |
-12% |
| #59 |
Weave Comms |
WEAV |
Packaged Software |
$583 |
92 |
100% |
16% |
-- |
-- |
| #60 |
Centerra Gold |
CGAU |
Precious Metals |
$4,503 |
92 |
40% |
61% |
-- |
-- |
| #61 |
Fatpipe |
FATN |
Packaged Software |
$81 |
91 |
999% |
28% |
1-Jun-26 |
-26% |
| #62 |
Star Bulk Carriers |
SBLK |
Marine Shipping |
$3,637 | 91 |
999% | 44% |
-- | -- |
| #63 |
ChipMOS Tech |
IMOS |
Semiconductors |
$2,159 |
91 |
264% |
26% |
-- |
-- |
| #64 |
Paymentus |
PAY |
Commercial Services |
$2,212 | 91 |
67% | 29% |
10-Aug-26 |
-9% |
| #65 |
Ooma Inc |
OOMA |
Major Telecom |
$627 |
91 |
52% |
25% |
-- |
-- |
| #66 |
AppFolio |
APPF |
IT Services |
$5,170 |
91 |
24% |
19% |
-- |
-- |
| #67 |
Karooooo |
KARO |
Packaged Software |
$2,060 |
91 |
19% |
36% |
-- |
-- |
| #68 |
Cohu, Inc. |
COHU |
Semiconductors |
$2,734 | 90 |
999% | 38% |
-- | -- |
| #69 |
Meridian Holdings |
MRDN |
Casinos/Gaming |
$178 |
90 |
147% |
16% |
-- |
-- |
| #70 |
National Energy Services |
NESR |
Oilfield Services/Equipment |
$3,286 |
90 |
110% |
59% |
-- |
-- |
| #71 |
Protagonist Therapeutics |
PTGX |
Pharmaceuticals: Major |
$9,253 |
90 |
516% |
3749% |
-- |
-- |
| #72 |
GEO Group |
GEO |
Commercial Services |
$4,180 | 90 |
68% | 15% |
08-06-26 |
+18% |
| #73 |
Matson |
MATX |
Marine Shipping |
$6,965 |
90 |
46% |
17% |
-- |
-- |
| #74 |
ScanSource |
SCSC |
Electronics Distributors |
$1,146 | 90 |
43% | 17% |
-- | -- |
| #75 |
Victory Capital |
VCTR |
Investment Managers |
$6,554 |
90 |
41% |
25% |
-- |
-- |
| #76 |
HNI Corp |
HNI |
Office Equipment/Supplies |
$3,328 |
90 |
14% |
121% |
-- |
-- |
| #77 |
Elemental Royalty |
ELE |
Oil & Gas Production |
$1,542 |
89 |
999% |
162% |
-- |
-- |
| #78 |
FutureFuel |
FF |
Chemicals: Specialty |
$244 | 89 |
999% | 121% |
-- | -- |
| #79 |
Greenfire Resources |
GFR |
Integrated Oil |
$1,601 |
89 |
999% |
39% |
-- |
-- |
| #80 |
Preformed Line Products |
PLPC |
Building Products |
$2,016 |
89 |
999% |
25% |
-- |
-- |
| #81 |
Uranium Royalty |
UROY |
Other Metals/Minerals |
$1,720 |
89 |
999% |
114% |
-- |
-- |
| #82 |
Daily Journal |
DJCO |
Publishing: Newspapers |
$898 | 89 |
999% | 15% |
-- | -- |
| #83 |
AvePoint |
AVPT |
Packaged Software |
$2,791 |
89 |
171% |
22% |
-- |
-- |
| #84 |
Webull |
BULL |
Packaged Software |
$3,679 | 89 |
99% | 51% |
8-Sep-26 |
-13% |
| #85 |
Fortuna Mining |
FSM |
Precious Metals |
$3,537 |
89 |
71% |
39% |
-- |
-- |
| #86 |
Aura Minerals |
AUGO |
Other Metals/Minerals |
$7,394 |
88 |
198% |
76% |
-- |
-- |
| #87 |
Fennec Pharma |
FENC |
Biotechnology |
$372 |
88 |
145% |
85% |
-- |
-- |
| #88 |
QuinStreet |
QNST |
Advertising Services |
$1,002 | 88 |
100% | 43% |
10-Aug-26 |
-17% |
| #89 |
MeiraGTx |
MGTX |
Biotechnology |
$1,273 |
88 |
456% |
8609% |
-- |
-- |
| #90 |
Imperial Petroleum |
IMPP |
Marine Shipping |
$258 |
88 |
100% |
140% |
-- |
-- |
| #91 |
XP Inc. |
XP |
Investment Banks/Brokers |
$8,309 |
88 |
14% |
21% |
-- |
-- |
| #92 |
Navigator Holdings |
NVGS |
Marine Shipping |
$1,537 | 87 |
508% | 30% |
-- | -- |
| #93 |
TWFG, Inc. |
TWFG |
Insurance Brokers/Services |
$344 |
87 |
90% |
45% |
-- |
-- |
| #94 |
Ero Copper |
ERO |
Other Metals/Minerals |
$3,564 | 87 |
80% | 74% |
-- | -- |
| #95 |
BILL Holdings |
BILL |
Packaged Software |
$4,057 |
87 |
58% |
14% |
-- |
-- |
| #96 |
Materion Corp |
MTRN |
Electronic Equipment |
$5,240 |
87 |
39% |
42% |
-- |
-- |
| #97 |
Scorpio Tankers |
STNG |
Marine Shipping |
$4,365 |
86 |
232% |
78% |
-- |
-- |
| #98 |
Avnet |
AVT |
Electronics Distributors |
$7,889 | 86 |
181% | 48% |
-- | -- |
| #99 |
Silicon Motion |
SIMO |
Semiconductors |
$9,227 |
86 |
252% |
123% |
-- |
-- |
| #100 |
Kronos Worldwide |
KRO |
Chemicals: Specialty |
$922 |
86 |
263% |
13% |
-- |
-- |
--Column originally published on September 21, 2026, by lead analyst Robert Reid, along with contributing analysts Dennis Hobein and Hayden Sweet - Briefing.com
|